LISA MAHEU: Open Payments
NPI 1215952239 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 36 payments from 11 companies in 2025. Trend: 2023 $698 · 2024 $940 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $222 |
| Novartis Pharmaceuticals Corporation | 6 | $135 |
| BridgeBio Pharma, Inc. | 4 | $110 |
| Edwards Lifesciences Corporation | 2 | $98 |
| Abbott Laboratories | 2 | $65 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Medtronic, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: VYNDAQEL, LEQVIO, Attruby, AVEIR, ELIQUIS, ONPATTRO, JARDIANCE, Kerendia.
Industry payments across MA — which companies pay providers there.
